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Abstract
Background: MFN1032 is a clinical Pseudomonas fluorescens strain able to grow at 37°C. MFN1032 cells induce necrosis 
and apoptosis in rat glial cells at this temperature. This strain displays secretion-mediated hemolytic activity involving 
phospholipase C and cyclolipopeptides. Under laboratory conditions, this activity is not expressed at 37°C. This activity 
is tightly regulated and is subject to phase variation.
Results: We found that MFN1032 displays a cell-associated hemolytic activity distinct from the secreted hemolytic 
activity. Cell-associated hemolysis was expressed at 37°C and was only detected in vitro in mid log growth phase in the 
presence of erythrocytes. We studied the regulation of this activity in the wild-type strain and in a mutant defective in 
the Gac two-component pathway. GacS/GacA is a negative regulator of this activity. In contrast to the Pseudomonas 
fluorescens strains PfO-1 and Pf5, whose genomes have been sequenced, the MFN1032 strain has the type III secretion-
like genes hrcRST belonging to the hrpU operon. We showed that disruption of this operon abolished cell-associated 
hemolytic activity. This activity was not detected in P.fluorescens strains carrying similar hrc genes, as for the P. fluorescens 
psychrotrophic strain MF37.
Conclusions: To our knowledge this the first demonstration of cell-associated hemolytic activity of a clinical strain of 
Pseudomonas fluorescens. Moreover, this activity seems to be related to a functional hrpU operon and is independent of 
biosurfactant production. Precise link between a functional hrpU operon and cell-associated hemolytic activity remains 
to be elucidated.
Background
Pseudomonas fluorescens is a highly heterogeneous spe-
cies, as shown the extensive literature on the taxonomy
and phylogeny of this species [1-4]. These studies include
saprophytic, rhizopheric and phytopathogenic strains of
P. fluorescens, illustrating the ubiquity of this species.
Most studies describe P. fluorescens as a psychrotrophic
bacterium unable to grow at temperatures greater than
32°C and therefore as an avirulent bacterium in humans.
Nevertheless, previous studies of the infectious potential
of P. fluorescens have demonstrated that the rifampicin
spontaneous mutant MF37 [5] derived from the environ-
mental psychrotrophic strain MF0 [6] can bind specifi-
cally to the surface of neurons and glial cells [7]. This
adhesion to the host cell is associated with the induction
of apoptosis and necrosis in glial cells [8]. Lipopolysac-
charides (LPS) produced or released by P. fluorescens
have a clear role in cytotoxicity, but other factors released
at the same time during adhesion also seem to be essen-
tial for the virulence of this bacterium [9]. Thus the vari-
ous enzymes secreted by this species may also be
considered as potential high virulence factors [5].
We recently demonstrated that the clinical strain
MFN1032 is a Pseudomonas fluorescens sensus stricto
Biovar1 strain able to grow at 37°C [10]. This strain has
hemolytic activity mediated by secreted factors, similar to
the hemolytic activity seen for the opportunistic patho-
gen Pseudomonas aeruginosa, involving phospholipase C
(PlcC) and biosurfactant [11]. Under specific conditions,
MFN1032 forms colonies of phenotypic variants, which
are defective in secreted hemolysis. Spontaneous muta-
tions of the genes encoding the two-component regula-
tory system GacS/GacA have been identified as the cause
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of phenotypic variation in one such group of variants. We
hypothesized that phenotypic variation increases the vir-
ulence potential of this strain. However these group vari-
ants (group 1 variants) do not produce secondary
metabolites and have impaired biofilm formation [12].
Then, these results suggested that virulence of MFN1032
is not dependent solely on secreted factors or LPS and
thus must involve other factors.
Some bacterial virulence factors are only expressed in
the presence of eukaryotic cells. This is the case of the
type III secretion system (TTSS), one of the most fre-
quently described contact dependent secretion systems
in Pseudomonas. TTSSs are found in many Gram-nega-
tive pathogens. They allow the direct translocation of
bacterial effector proteins into the cytoplasm of eukary-
otic host cells. P. aeruginosa uses the TTSS to translocate
four effector proteins (ExoS, ExoT, ExoU, and ExoY) with
antihost properties [13]. The P. aeruginosa TTSS consists
of nearly 40 genes, regulated in a coordinated manner
and encoding structural components of the secretion and
translocation machinery, effectors proteins, and regula-
tory factors [14]. Transcription of the TTSS is induced
under calcium-limited growth conditions or following
intimate contact of P. aeruginosa with eukaryotic host
cells [15]. Pseudomonas syringae pv. tomato DC3000 is a
phytopathogenic bacterium that harbors a gene cluster
hrp (for hypersensitive reaction and pathogenicity). This
hrp  cluster is essential for pathogenicity in susceptible
plants and for the ability to elicit the hypersensitive reac-
tion in nonhosts or resistant cultivars of host plants [16].
hrp genes are expressed in planta or in media mimicking
plant apoptotic conditions [17]. Sequence analyses have
uncovered a shared subset of nine hrp genes that were
renamed  hrc  (for  hrp  and conserved) and that encode
proteins homologous to Yersinia ysc gene products [18].
The existence of these genes suggests evolutionary con-
servation of molecular mechanisms of pathogenicity used
by both mammalian and phytopathogenic bacteria [19].
In P. fluorescens, the presence of the hrc genes belong-
ing to hrpU operon depends on the strain. The feature of
TTSS and the origin of hrc genes remain to clarify in this
species [20-23].
In the present study, we describe the detection of cell-
associated hemolytic activity of P. fluorescens MFN1032
in contact with sheep erythrocytes. This hemolytic activ-
ity was compared with the hemolytic activity of other P.
fluorescens  strains: a spontaneous MFN1032 gacA
mutant and the opportunistic pathogen Pseudomonas
aeruginosa CHA [24]. Cell-associated hemolytic activity
and its regulation were compared with the activity and
regulation of the previously described secreted hemolytic
activity of MFN1032. We then looked for hrc genes in our
strain and determined their role in the cell-associated
hemolytic activity of MFN1032, using hrpU operon dis-
ruption mutant.
Results
MFN1032 displays cell-associated hemolytic activity
Hemolytic activity of Pseudomonas fluorescens biovar I
MFN1032 and Pseudomonas aeruginosa CHA (positive
control for TTSS-mediated hemolysis) was measured by
the technique employed by Dacheux [25], adapted as
described in methods.
Bacteria were grown at 37°C to mid exponential growth
phase and were used at a multiplicity of infection (MOI)
of 1, without spin (which enhance contact between bacte-
ria and RBCs). CHA induced lysis of 5% of red blood cells
(RBCs) and MFN1032, 50% lysis, within 1 hour at 37°C.
Hemolytic activity of CHA was increased by a 10 min
centrifugation at 400 g (20% lysis) or 1500 g (70% lysis).
By contrast, the hemolytic activity of MFN1032 was
unchanged after a 10 min centrifugation at 400 g and
reduced by centrifugation at 1500 g (35% lysis) (Figure 1).
For further experiments we used a 10 min centrifugation
at 400 g since this protocol is allowing close contact
between bacterial cells and RBCs and appears compatible
with maximum lysis by MFN1032. Supernatants from
MFN1032 cells tested in the same conditions had no
hemolytic activity. Additionally, we collected superna-
tants from RBC lysed by MFN1032. Supernatants were
filtered and incubated with fresh RBCs for 1 h at 37°C.
This supernatant from lysed RBC samples did not induce
further RBC lysis. Thus, the factor mediating RBC lysis is
not a factor released into the supernatant, but is depen-
dent on the presence of MFN1032 cells.
MFN1032 cells from cultures grown to the exponential
growth phase at various temperatures were incubated
with RBCs for 1 h at 37°C. MFN1032 bacteria grown at
17°C and 37°C showed the same levels of hemolysis (50%
of RBCs lysed), whereas bacteria grown at 8°C were
almost devoid of hemolytic activity (5% lysis). The maxi-
mal hemolytic activity of MFN1032 was observed at 28°C
(70% lysis), the optimal growth temperature of this strain
(Figure 2).
Lysis of RBCs is caused by a pore-forming toxin from 
MFN1032
We investigated the nature of the factor involved in RBC
lysis by osmoprotection experiments. Osmoprotectants
protect RBCs against osmotic shock provoked by bacte-
rial pore-forming toxins. We used different sized mole-
cules in hemolysis experiments to estimate the size of the
pore formed in the RBC membrane (Figure 3). We did not
observe any effects on hemolysis with PEG300, PEG600,
PEG1500 or PEG2000. Molecules larger than PEG2000
protected against MFN1032 cell-associated hemolysis asSperandio et al. BMC Microbiology 2010, 10:124
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observed for PEG3000. A maximal level of protection was
reached with PEG4000, resulting in the protection of 90%
of RBCs against this hemolytic process. Based on these
results, we estimated the size of the pore formed in RBC
membranes by MFN1032 is between 2.4 nm and 3.2 nm.
MFN1032 cell-associated hemolytic activity is higher than 
in other Pseudomonas fluorescens strains
We tested the hemolytic activity of MFN1032, MFY162 (a
clinical isolate of Pseudomonas fluorescens Biovar I),
MFY161 and MFY163 (clinical isolates of Pseudomonas
mosselli) [10], MF37 (Pseudomonas fluorescens biovar V,
derived from a psychrotrophic environmental strain) and
C7R12 (a psychrotrophic rhizospheric strain) cells at 28
and 37°C.
The hemolytic effect of MFN1032 cells was much
higher than the other strains tested, at both growth tem-
peratures (Figure 4). At 28°C, MFY162 was the only other
strain showing high levels of hemolytic activity (40%
lysis); MFY161 and MFY163 displayed only weak hemo-
lytic activity (5-10% lysis). All clinical isolates showed
some hemolytic activity (15% lysis) at 37°C, but at a lower
level than that observed for MFN1032 one's. The envi-
ronmental strains tested were not hemolytic at 28°C and
did not grow at 37°C.
The hemolytic activities of MFN1032, MFY162 and
MFY161, were maximal at their optimal growth tempera-
ture (28°C for MFN1032 and MFY162, 37°C for MFY
161). The hemolytic activity of the strain MFY163 was
the same at 28°C and 37°C.
Involvement of the Gac two-component system on cell-
associated hemolytic activity
We investigated the possible involvement of the Gac two-
component system in the regulation of this cell-associ-
ated hemolytic activity using a group1 variant of
MFN1032, V1. This variant strain is a gacA mutant and
has impaired secreted hemolytic activity [12]. V1 was
tested with or without transformation by electroporation
with plasmid carrying the gacA gene (pMP5565) or the
parental plasmid pME6010, as a control [26] (Figure 5).
The non-transformed V1 strain displayed enhanced
hemolytic activity (160% lysis), using MFN1032 as a refer-
ence value (100%). Introduction of a gacA gene in V1 cells
by electroporation with pMP5565 restored wild-type
hemolytic levels.
Figure 1 Comparison of the hemolytic activity of MFN1032 and CHA and characterization of MFN1032 cell-associated hemolysis. Hemolysis 
of RBCs (% HA) incubated with MFN1032 and CHA, at 37°C and with a multiplicity of infection (MOI) of 1. Cells were subjected or not to centrifugation 
at 1500 g or 400 g for 10 min to enhance cell-cell contact. cHA indicates cell-associated hemolytic activity and sHA indicates secreted hemolytic ac-
tivity. MFN1032 sup indicates MFN1032 cell-free supernatant. MFN1032 stat indicates MFN1032 cells in stationary growth phase. MFN1032 sup lysis 
indicates supernatants obtained after RBC lysis by MFN1032. Hemolytic activity was measured as described in the materials and methods. Results are 
means of at least three independent experiments. Standard deviation is shown.Sperandio et al. BMC Microbiology 2010, 10:124
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MFN1032 has hrcRST genes
The lysis of RBCs by a number of bacteria requires the
formation of a pore in the erythrocyte membrane by
TTSS protein. To determine whether TTSS-like genes are
present in MFN1032 and MF37, we used PCR primers
targeting hrpU operon, (so called U operon of the hrp
cluster of type I) encoding the conserved core proteins of
fluorescent Pseudomonas TTSS, described by Mazurier
et al. [23]. The region amplified by these primers includes
the 3'end of hrcR, hrcS and the 5'end of hrcT.
A single fragment of 0.9 kb was obtained for MFN1032
and MF37 and cloned with the pMOS kit. Fragments
were sequenced by Genome Express (France). Sequences
were registered in the Genbank database (accession num-
ber: EU811174 for MFN1032 and FJ694188 for MF37)
and named "hrc  operon", partial sequence. These
sequences predict an 87 residues HrcS protein in these
two strains.
A NCBI nucleotide and protein database search
showed that the putative HrcS from MFN1032 was very
similar to the putative MF37 HrcS (90% identity) and to
RscS (94% identity), a type III secretion protein from the
Pseudomonas fluorescens strain SBW25 (belonging to the
HrcS/YscS/FliQ family), but is more distantly related to
the HrcS of C7R12 (73.9% identity) (Table 1). The P.
aeruginosa PAO1 FliP partial protein showed 47% iden-
tity.
Effect of disruption of the hrpU operon
We investigated a possible link between this hrpU operon
and the cell-associated hemolytic activity of MFN1032.
We used a mutant strain, MFN1030, in which the hrpU
operon was disrupted, to determine whether TTSS pro-
teins are required for the hemolytic activity observed in
MFN1032. In this construction, the single homologue
recombination provokes at least the deletion of the 5'-end
of hrcT (58% of HrcT) and of genes situated downstream
hrcT in this operon (Figure 6). We observed an almost
total loss of cell-associated hemolytic activity (10% lysis)
in the mutant strain. Revertant of MFN1030, the strain
MFN1031, had a restored hemolytic phenotype, showing
activity levels similar to those of MFN1032 (Figure 7A).
These results demonstrate a link between the hrpU
operon and this cell-associated hemolytic activity in P.
fluorescens MFN1032.
Given the homology between hrcS and fliP, we investi-
gated the potential role of hrcRST genes in flagellar syn-
Figure 2 Influence of growth temperature on MFN1032 cell-associated hemolytic activity. Cell-associated hemolytic activity (cHA %) was mea-
sured for MFN1032 grown at 8°C, 17°C, 28°C (optimum growth temperature) or 37°C, as described in the materials and methods. Results are means 
of at least three independent experiments. Standard deviation is shown. Contact was enhanced by centrifugation at 400 g for 10 min.
     8°C                          17°C                           28°C                        37°C
Growth temperature (°C)Sperandio et al. BMC Microbiology 2010, 10:124
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thesis. The effect of disrupting the hrpU  operon in
MFN1030 was measured in swimming mobility assays, as
described in the methods. At 28°C, we observed no dif-
ferences in swimming ability between MFN1032,
MFN1030 and MFN1031 (Figure 7B), suggesting that dis-
ruption of this operon has no effect on flagella motility.
Discussion
To our knowledge this is the first study to demonstrate
cell-associated hemolytic activity in clinical isolates of a
Pseudomonas fluorescens. P.fluorescens MFN1032 cell in
exponential growth phase displayed hemolytic activity at
37°C, whereas no hemolytic activity was detected using
MFN1032 supernatant. This hemolytic activity was thus
dependent on the presence of MFN1032 cells. MFN1032
cells caused hemolysis of RBCs without requiring prior
centrifugation to reduce the distance between bacterial
and red cell membrane below a critical threshold. Such a
centrifugation step has previously been shown to be nec-
essary to induce the "contact-dependent" hemolytic activ-
Figure 3 Protection of RBCs from cell-associated hemolysis by osmoprotectants. Omoprotectants were added at a final concentration of 30 
mM. All experiments were performed at least three times in triplicate. MFN1032 was grown at 28°C. Standard deviation is shown.
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Figure 4 Cell-associated hemolytic activity of different fluorescent Pseudomonas strains. Cell-associated hemolytic activity (cHA %) was mea-
sured as described in the materials and methods. Results are means of at least three independent experiments. Standard deviation is shown. A: Hemo-
lysis of RBCs incubated with MFN1032, MF37, C7R12, MFY161, MFY162, MFY163 at 28°C and MOI of 1. Contact was enhanced by centrifugation at 400 
g for 10 min. B: Hemolysis of RBCs incubated with MFN1032, MF37, C7R12, MFY161, MFY162, MFY163 at 37°C and MOI of 1. Contact was enhanced by 
centrifugation at 400 g for 10 min. ND: not determined. MF37 and C7R12 were unable to grow at 37°C.
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ity displayed by several other bacteria, for example
Yersinia [27], Shigella [28] and Pseudomonas aeruginosa
[25]. In contrast, "induced" hemolysis does not require
close RBC-bacterial contact for enteropathogenic Escher-
ichia coli EPEC, due to the long EspA (TTSS secreted
protein) filaments that form a connection between bacte-
ria and host cells for protein translocation [29,30].
MFN1032 hemolytic activity was not strictly contact-
dependent but depended on the presence of MFN1032
cells. We therefore propose the term "cell-associated"
hemolytic activity.
This activity is independent of the secreted hemolytic
activity previously described for this strain. For all tested
conditions, we have previously demonstrated that
secreted hemolytic activity only occurs at the end of the
exponential growth phase [11]. MFN1032 supernatants
were not hemolytic at 37°C in vitro and hemolysis was
maximal at 17°C. Cell-associated hemolysis measured
here was maximal during the exponential growth phase
and retrieved at 37°C. Moreover, a gacA  mutant of
MFN1032 (V1), for which several extracellular activities
are impaired (including secreted hemolytic activity),
showed increased cell-associated hemolytic activity. In
psychrotrophic bacteria, most secreted enzymes are gen-
erally found at 17°C (critical temperature), whereas mem-
brane-associated activities are enhanced with decreased
generation time [6,31]. Thus, the maximum expression of
this new hemolytic activity at 28°C (optimal growth tem-
perature) is consistent with a cell surface associated pro-
cess.
This hemolytic activity is not common to all Pseudomo-
nas fluorescens species. Indeed, we only observed signifi-
cant cell-associated hemolysis in the clinical strains
MFN1032 and MFY162 and not in the environmental
Figure 5 Effect of GacA on MFN1032 cell-associated hemolytic 
activity. Cell-associated hemolytic activity (cHA) for MFN1032 cells, V1 
(gacA mutant) and V1 cells carrying the gacA gene-containing plasmid 
(pMP5565), or the parental plasmid pME6010 used as a control. The 
cHA of MFN1032 was taken as the reference value (100%); results are 
expressed as percent of this value (% relative cHA). The strains were 
grown at 28°C. Results are means of at least three independent exper-
iments. Standard deviation is shown. Contact was enhanced by centrif-
ugation at 400 g for 10 min.
Table 1: Comparison of the MFN1032 HrcS sequence with other Hrc-like sequences
Strain HrcS-like
GenBank number
% Identity to HrcS
MFN1032
P.fluorescens MFN1032 Putative HrcS
ACE88958
-
P.fluorescens SBW25 Putative type III secretion membrane 
protein RscS
CAY46985
94%
P. fluorescens Pf-5 Flagellar biosynthesis protein FliQ
AAY90949
NS
P. fluorescens MF37 Putative HrcS
ACO58571
90%
P. fluorescens Pf0-1 Flagellar biosynthesis protein FliQ
ABA73293
NS
P. fluorescens C7R12 Putative HrcS
CAC24707
74%
P.aeruginosa PAO1 FliP
AAG04835
47%
Pseudomonas syringae pv. tomato str. 
DC3000
Type III secretion protein HrcS
AAO54916
76%
Pseudomonas syringae pv. phaseolicola 
1448A
Type III secretion component protein HrcS
CAE53643
74%
NS: not significant (< at 40%)Sperandio et al. BMC Microbiology 2010, 10:124
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strains tested. Although our panel of studied strains is
limited and can not be considered as representative, the
presence of this activity seems to be dependent on strain
origin, i.e clinical source. Cell-associated hemolytic activ-
ity has been rarely observed in environmental strains.
Nevertheless, two hemolytic strains showing such pheno-
type have been described for Plesiomonas shigelloides
(former Pseudomonas) [32].
We amplified TTSS-like genes hrcRST from MFN1032
and MF37 cells while P.fluorescens PfO-1 and Pf5 strains
[21,33] lack the TTSS genes found in related pathogens or
plant-associated bacteria. hrpU  operon-like has previ-
Figure 6 Construction of MFN1030 hrpU operon disrupted mutant. phrpU indicates the promoter of hrpU operon. tet is the tetracycline resistance 
gene of pME3087. The length of each hrc gene is indicated below its designation (in base pairs). 3'hrcR indicates hrcR gene deleted in 5'-end and 5'hrcT 
indicates hrcT gene deleted in 3'-end. The arrow above the genes represents the operon transcription. A bold line represents DNA from pME3087. 
HindIII and EcoRI are enzymes used to clone hrcRST in pME3087. Unknown indicates putatives hrc genes located upstream or downstream hrcRST 
genes.
Unknown  hrcR        hrcS  5’hrcT 3’ hrcR hrcS     hrcT       Unknown
Upstream downstream
MFN1032
MFN1030
EcoRI
pME3087-hrcRST (7,8 Kb) tet
hrpU operon transcription
phrpU
phrpU
hrpU operon transcription
Single homologue recombinaison 
hrcR hrcS hrcT
560       263        960
Unknown
upstream
Unknown
downstream
3‘hrcR hrcS 5’hrcT
Hind III
145    263     403
tet
Figure 7 Cell-associated hemolytic activity and swimming motility of MFN1032, MFN1030 (MFN1032 hrcRST-disrupted mutant) and 
MFN1031 (revertant). A: Hemolysis of RBCs incubated with MFN1032, MFN1030 and MFN1031 at 28°C and a MOI of 1. Results are means of at least 
three independent experiments. Standard deviation is shown. Contact was enhanced by centrifugation at 400 g for 10 min. B: Swimming motility of 
MFN1032, MFN1030 and MFN1031. Swimming motility was determined, as described in the methods, on 0.3% LB agar after 16 h of incubation at 28°C. 
MFN1032, MFN1031 and MFN1030 formed concentric halos corresponding to swimming motility.
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ously been found in the P. fluorescens strains KD (phyto-
protection strain) and SBW25 (biocontrol strain) [22,34].
In one study of a group of fluorescent Pseudomonas,
TTSS-like genes were detected in 75% of the phytopatho-
genic but only in 32% of the saprophytic strains tested
[23]. The presence of hrcRST genes is not systematically
correlated to hemolytic activity. Indeed, P. fluorescens
MF37 and C7R12 have similar hrcRST genes to MFN1032
but are not hemolytic. Thus, the presence of these genes
does not strictly imply hemolytic function. Lysis is depen-
dent upon the ability of TTSS translocator proteins to
form a pore in the erythrocyte membrane causing hemo-
globin leakage. The presence of these hrcRST genes does
not necessarily result in the assembly of a functional
TTSS. Some TTSS genes are absent from SBW25 and
TTSS virulence genes in KD have been suggested to have
been recently acquired horizontally from phytopatho-
genic bacteria and recycled for biocontrol function [22].
TTSS-dependent lysis of erythrocytes has been
observed in a number of bacteria. Contact-dependent
hemolysis assays have been used to identify the genes
required for a functional Salmonella  TTSS 1 [35].
MFN1032 cell-associated hemolytic activity shares com-
mon features with TTSS-mediated hemolysis. The vari-
ous mechanisms involved include formation of a pore
with an estimated size of 2.4 to 3.2 nm, consistent with
TTSS-hemolysis mechanism previously described by
Dacheux for Pseudomonas aeruginosa [25]. MFN1032
cells did not show this cell-associated hemolysis during
the stationary growth phase. Previous studies have shown
a negative effect of high cell density, through a RpoS-
mediated mechanisms [36] or by quorum-sensing [37],
on TTSS gene expression in Pseudomonas aeruginosa.
We found increased hemolytic activity in the MFN1032
gacA mutant (V1). This result suggests that the Gac two-
component system is a negative regulator of cell-associ-
ated hemolytic activity. Studies on TTSS regulation in
Pseudomonas aeruginosa have demonstrated that the
GacA response regulator inhibits TTSS function and
that, in a gacA mutant, the TTSS effector ExoS is hyper-
secreted [38]. Opposite, in Pseudomonas syringae, GacA
is a positive regulator of the TTSS [39]. The homology
between MFN1032 genes and plant-associated TTSS
genes is not in favour of a direct negative transcriptional
regulation by the system Gac.
To investigate the potential role of TTSS in this hemo-
lytic process, we constructed a mutant with hrpU operon
disruption, MFN1030, in which hemolytic activity was
severely impaired. Hemolysis was restored in revertant
MFN1031 cells, with hemolytic activity levels similar to
wild type. Thus, cell-associated hemolytic activity seems
to require an intact hrpU  operon. In contrast, hrpU
operon disruption did not affect swimming motility, sug-
gesting that hrpU operon is not involved in flagella bio-
synthesis. In MFN1030 the single homologue
recombinaison event with PME3087-hrcRST would
result in, at least, a lack of HrcT protein. In Pseudomonas
cichorri, an insertion of transposon in hrcT was described
as sufficient to lost virulence on eggplant [40]. This large
insertion in MFN1030 would have a polar effect on genes
situated downstream this operon. In Pseudomonas fluo-
rescens, hrcRST genes are highly conserved. Other genes
of the hrpU operon, however, seem to vary considerably
[22,34]. PCR experiments based on SBW25 and KD
sequences did not lead to an amplification of any hrc
genes located downstream or upstream hrcRST (data not
shown). An experiment of chromosome walking should
allow us to identify these genes.
The  hrcRST  genes from Pseudomonas fluorescens
MFN1032 show a high level of homology with hrcRST
genes from Pseudomonas syringae, a plant pathogen.
TTSS-dependent pore formation is due to the insertion
of the translocation pores into host cell membranes. In
Pseudomonas syringae, Hrpzpsph forms pores in vitro and
is exported by the TTSS. However, when introduced into
Yersinia enterocolitica cells, this protein is exported via
the Yersinia SSTT but cannot replace YopB functions and
do not cause RBC hemolysis [19]. HrpZ is unable to
induce pore formation. Moreover, in the two strains of
Pseudomonas fluorescens already described no hrpZ
homologue was found. We tried to amplify this gene with
primers design from hprZ from other pseudomonad, but
without success.
The nature of the TTSS component implicates in the
cell hemolytic activity of MFN1032 remains to be deter-
mined. We will address this issue in future studies.
Conclusion
Pseudomonas fluorescens MFN1032 is a clinical strain
isolate that displays two distinct types of hemolytic activ-
ity, described here for the first time. The first type is
observed in the cell-free supernatant of rich media cul-
tures at 28°C, whereas the second, cell-associated type of
hemolysis, is detected at 37°C in the presence of erythro-
cytes. This strain has hrcRST genes, a feature that is not
shared by all Pseudomonas fluorescens strains. Our study
establishes an unexpected link between these hrc genes
and cell-associated hemolytic activity. These initial find-
ings are consistent, although not sufficient, to demon-
strate that this cell-associated hemolysis is due to a
functional TTSS. Investigation of type III effector genes
in the genome of this strain and the construction of tar-
geted mutants are now needed to confirm these findings.
Nevertheless, this study suggests that certain strains of
the highly heterogeneous species Pseudomonas fluore-
scens, which is usually considered to be a saprophytic spe-
cies, express virulence with characteristic of pathogenic
species belonging to the Pseudomonas genus. Neverthe-Sperandio et al. BMC Microbiology 2010, 10:124
http://www.biomedcentral.com/1471-2180/10/124
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less the principal role of this TTSS homologue to the one
of plant-associated bacteria is probably not the pathoge-
nicity against endotherms. The first target of this system
would rather be unicellular eukaryotes of the rhizo-
sphere, as mycetes or amoebas.
Methods
Bacterial strains and culture conditions
The MFN1032 strain was collected from a hospital
patient suffering from pulmonary tract infection (expec-
toration) and was considered to be the cause of the infec-
tion. MFN1032 was identified as a Pseudomonas
fluorescens biovar I strain [10] and was able to grow at
37°C.
CHA is a bronchopulmonary isolate of Pseudomonas
aeruginosa from a cystic fibrosis patient [24]. This strain
induces TTSS-dependent but ExoU-independent oncosis
of neutrophils and macrophages. CHA-induced mac-
rophage death results from a pore forming activity that is
dependent on the TTSS. Contact dependent hemolysis
provoked by CHA requires the same pore forming activ-
ity. CHA has a well inducible and tightly regulated TTSS
[41], and is used in our study as a positive control of RBC-
TTSS hemolysis.
MF37 is a spontaneous rifampicin-resistant mutant of
the MFO strain, a psychrotrophic strain of Pseudomonas
fluorescens biovar V, isolated from raw milk and exten-
sively studied in our laboratory [5].
MFY162 is a clinical isolate of Pseudomonas fluorescens
Biovar I, MFY161 and MFY163 are clinical isolates of
Pseudomonas mosselli [10] and C7R12 a Pseudomonas
fluorescens psychrotrophic rhizospheric strain [42].
These bacteria were cultured in Luria Bertani medium
(LB), at various temperatures between 8 and 37°C, with
shaking at 180 rpm. When necessary, 20 μg/mL tetracy-
cline or 100 μg/mL ampicillin was added. Bacterial den-
sity was determined by measuring optical density at 580
nm (Spectronic Unicam spectrophotometer).
Swimming motility
Each strain was incubated on LB agar plates for 24 h at
28°C. Plates of LB medium solidified with 0.3% agar were
inoculated by stabbing colonies with a toothpick and
inserting the end of the toothpick just below the surface
of the agar. Three colonies were picked from three plates
and incubated at 28°C until a migration halo appeared.
Hemolysis assay
Hemolysis was performed essentially as described by
Dacheux [25]. Sheep red blood cells (RBCs), obtained
from Eurobio (France), were washed three times in PBS
(pH 7.2, 0.8% NaCl, 0.02% KCl, 0.17% Na2HPO4, 0.8%
KH2PO4) and resuspended in RPMI-1640 medium with-
out pH indicator (Sigma) at a density of 5 × 108 RBCs mL-
1 at 4°C. Bacteria were grown in LB to an OD580 nm of 0.7 -
1.5, centrifuged and resuspended in RPMI-1640 at 5 × 108
bacteria mL-1. Hemolysis assays were started by mixing
100 μL of RBCs and 100 μL of bacteria, which were than
centrifuged at 1500 g or 400 g for 10 minutes and incu-
bated at 37°C for 1 h. The release of hemoglobin was
measured at 540 nm, after centrifugation, in 100 μL of cell
supernatant.
The percentage (%) of total lysis was calculated as fol-
lows: % = [(X -B)/(T-B)] × 100, where B (baseline), a neg-
ative control, was corresponding to RBCs incubated with
100 μL of RPMI-1640, and T, a positive control, was cor-
responding to total RBCs lysis, obtained by incubating
cells with 0.1% SDS. X is the OD value of the analysed
sample.
When indicated, RBCs were resuspended in 60 mM
sterile solutions of osmoprotectant in RPMI-1640, to give
a final concentration of 30 mM. For these experiments, a
control of hemoglobin precipitation in presence of PEG
4000 and PEG 3000 was realized [43]. PEG 3000 or 4000
were added to a RBCs lysis supernatant obtained after
incubation with MFN1032 at a final concentration of 30
mM. No variation of hemoglobin OD value was observed
in our conditions during incubation at 37°C for 1 h.
Oligonucleotides and polymerase chain reactions
MFN1032 and MF37 strains were resuspended in 500 μL
sterile ultrapure water. The suspension (2 μL) was then
used for PCR amplification of DNA from bacterial colo-
nies. PCR was carried out in a 25 μL reaction volume, in a
GeneAmp PCR system 2400 (Perkin-Elmer Corporation,
USA). Each reaction mixture contained DNA, 0.25 μL
Taq polymerase (Q-Biogen, Illkrirch, France), 2.5 μL cor-
responding buffer, 2.5 μL primers (20 μM) and 2 μL
deoxyribonucleoside triphosphate (2.5 mM). After initial
denaturation for three minutes at 95°C, the reaction mix-
ture was subjected to 35 cycles of 1 minute at 94°C, 1
minute at 41°C and two minutes at 72°C, followed by a
final 3 minutes extension at 72°C. PCR primers,
HRCR8092 (5'-CCITT(C/T)ATCGT(C/T)AT(C/T)GA
(C/T)(C/T)T-3') and HRCT8986 (5'-CTGTCCCAGATI-
AICTGIGT-3') (where I indicates inosine), synthesized by
E urogentec (Angers, F rance), were designed to am plify
the "hrc operon", a region of operon U of the hrp cluster
of type I (hrpU  operon), including the 3' end of hrcR
(26%), hrcS (100%), and the 5' end of hrcT (42%) (approxi-
mately 897 bp) [23].
Aliquots (5 μL) of the PCR products were analyzed by
electrophoresis in 1% agarose gels, stained with ethidium
bromide and photographed under UV illumination.
Cloning and sequencing the hrcRST PCR fragment
PCR products were cloned with the pMOSBlue blunt-
ended cloning kit (Amersham/Biosciences). MOS cellsSperandio et al. BMC Microbiology 2010, 10:124
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were transformed and, after blue/white colony screening,
clones were picked and plasmid DNA was isolated with
the QIAprep Spin Miniprep Kit (Qiagen).
The PCR products were sequenced by Genome Express
(France). The predicted sequences of MFN1032 hrcRST
and MF37 hrcRST were submitted for BLAST queries
http://www.ncbi.nlm.nih.gov/BLAST/.
Construction of MFN1030, an hrcU operon-disrupted 
mutant of MFN1032 and MF1031, its revertant
The hrcRST-pMOS plasmid from MFN1032 was digested
with EcoRI/HindIII and subsequently hrcRST fragment
was inserted into the transferable suicide plasmid
pME3087 (6,9 Kb) digested by the same enzymes [44].
This construction, pME3087-hrcRST (7,8 kb), was then
introduced into Escherichia coli DH5α MCR cells by elec-
troporation. Plasmids were isolated using the QIAprep
Spin Miniprep Kit (Qiagen), checked by digestion with
HindIII/EcoRI and transferred into the Escherichia coli
conjugative strain S17.1 [45]. Colonies were selected for
their resistance to tetracycline (20 μg/mL). MFN1032
(naturally ampicillin resistant) cells were conjugated with
S17.1 cells carrying the pME3087-hrcRST plasmid and
strains were selected for their resistance to tetracycline
(20 μg/mL) and ampicillin (100 μg/mL) that corresponds
to insertion of the whole plasmid via a single homologue
recombinaison. One of the clones was selected and corre-
sponded to an hrpU operon disruption mutant. This dis-
ruption mutant was called MFN1030. The reversion of
the mutant MFN1030 was obtained after incubating
MFN1030 cells on an LB agar plate for 72 hours. Of all
the colonies obtained, 100 were subcultured in parallel on
LB agar plates with or without tetracycline (20 μg/mL).
Colonies growing on LB agar pla tes without tetracy-
cline but not on LB agar plates with tetracycline (20 μg/
mL) reflect a second recombination event and an excision
of the plasmid. One clone was selected and named
MFN1031, a revertant of MFN1030 strain.
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